Form DEFM14A Amneal Pharmaceuticals,
Tweet
Share
E-mailhttp://archive.fast-edgar.com/20260629/AN22622CZM227TDU222L2Z42E5RLIC22Z282
Filed on: June 29, 2026
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Amneal Expands Iohexol Injection Portfolio with U.S. FDA Approval of Additional Strengths and Presentations
- Amneal to Report Second Quarter 2026 Results on July 30, 2026
- FDA approves new Amneal iohexol injection strengths for imaging use
Create E-mail Alert Related Categories
SEC FilingsRelated Entities
DEFM14ASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
